Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Krieg

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Nature Medicine|July 24, 2019
GM-CSF and CXCR4 define a T helper cell signature in multiple sclerosisEdoardo Galli, Felix J Hartmann, Bettina Schreiner, et al.
Cancer Research|June 21, 2020
IL6 Fuels Durable Memory for Th17 Cell-Mediated Responses to TumorsHannah M Knochelmann, Connor J Dwyer, Aubrey S Smith, et al.
Cell Reports|December 24, 2013
Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infectionObinna Chijioke, Anne Müller, Regina Feederle, et al.
Journal for Immunotherapy of Cancer|June 15, 2025
Multiomics identifies tumor-intrinsic SREBP1 driving immune exclusion in hepatocellular carcinomaRebekah E Dadey, Ruxuan Li, Jake Griner, et al.
Science Translational Medicine|January 10, 2020
Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-βAlessandra Metelli, Bill X Wu, Brian Riesenberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 2022
Phase I Trial Characterizing the Pharmacokinetic Profile of N-803, a Chimeric IL-15 Superagonist, in Healthy VolunteersMark P Rubinstein, Cameron Williams, Caroline Mart, et al.
Science Advances|July 20, 2022
Noncanonical activation of GLI signaling in SOX2<sup>+</sup> cells drives medulloblastoma relapseMarzena Swiderska-Syn, Júlia Mir-Pedrol, Alexander Oles, et al.
Cell Reports. Medicine|November 10, 2021
Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinomaSixue Liu, Hannah M Knochelmann, Shirley H Lomeli, et al.
The Lancet. Oncology|April 10, 2018
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trialJohn M Wrangle, Vamsidhar Velcheti, Manish R Patel, et al.
The Journal of Clinical Investigation|October 12, 2023
Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1Callum Beach, David MacLean, Dominika Majorova, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Nature Medicine|July 24, 2019
GM-CSF and CXCR4 define a T helper cell signature in multiple sclerosisEdoardo Galli, Felix J Hartmann, Bettina Schreiner, et al.
Cancer Research|June 21, 2020
IL6 Fuels Durable Memory for Th17 Cell-Mediated Responses to TumorsHannah M Knochelmann, Connor J Dwyer, Aubrey S Smith, et al.
Cell Reports|December 24, 2013
Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infectionObinna Chijioke, Anne Müller, Regina Feederle, et al.
Journal for Immunotherapy of Cancer|June 15, 2025
Multiomics identifies tumor-intrinsic SREBP1 driving immune exclusion in hepatocellular carcinomaRebekah E Dadey, Ruxuan Li, Jake Griner, et al.
Science Translational Medicine|January 10, 2020
Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-βAlessandra Metelli, Bill X Wu, Brian Riesenberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 2022
Phase I Trial Characterizing the Pharmacokinetic Profile of N-803, a Chimeric IL-15 Superagonist, in Healthy VolunteersMark P Rubinstein, Cameron Williams, Caroline Mart, et al.
Science Advances|July 20, 2022
Noncanonical activation of GLI signaling in SOX2<sup>+</sup> cells drives medulloblastoma relapseMarzena Swiderska-Syn, Júlia Mir-Pedrol, Alexander Oles, et al.
Cell Reports. Medicine|November 10, 2021
Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinomaSixue Liu, Hannah M Knochelmann, Shirley H Lomeli, et al.
The Lancet. Oncology|April 10, 2018
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trialJohn M Wrangle, Vamsidhar Velcheti, Manish R Patel, et al.
The Journal of Clinical Investigation|October 12, 2023
Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1Callum Beach, David MacLean, Dominika Majorova, et al.
Pageof 5